bearish

What Does a Trump Presidency Mean for China Healthcare?

Xinyao has highlighted this Insight as a Top Pick
389 Views22 Aug 2024 08:55
​Assassination of Trump boosts his election chances, but his healthcare reform may not benefit industry.US national security concerns over China's pharmaceutical supply chain increases decoupling risk
What is covered in the Full Insight:
  • Introduction
  • US Pharmaceutical Supply Chain Independence
  • Reduce Drug Prices
  • Other Concerns
  • Conclusion
Boomeranged on Thu, 7 Nov 2024 09:02
Trump successfully elected as the US President. His reform in healthcare is to achieve the independence of US pharmaceutical supply chain and reduce drug prices. China API/CXO would be the segments with big risk. Tariffs are likely to be reintroduced to weaken China's supply chain advantage/competitiveness. China Biotech with US revenue may also face headwinds. "Decoupling risk" further increases.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
x